StocksFin Logo
IQVIA Holdings Inc.
IQVIA Holdings Inc. country of incorporation
|
https://www.iqvia.com
|
Mr. Ari Bousbib
|
85,000 employees
NYSE | Healthcare | Diagnostics & Research
Takeda Pharmaceutical C...
Takeda Pharmaceutical Company Limited country of incorporation
|
https://www.takeda.com
|
Mr. Christophe Weber
|
47,347 employees
NYSE | Healthcare | Drug Manufacturers—Specialty & Generic
Q322 reported Oct 27, 2022 Reporting Period
$3.56B 5% vs. Q321 Revenues Q322
34.84% 3.8% vs. Q321 Gross Profit Margin
7.94% 3.2% vs. Q321 Net Profit Margin
698M -17.3% vs. Q321 Free Cash Flow Q322
$1.52 11.8% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q223
0.25%
Q223 reported Sep 30, 2022 Reporting Period
$1T 18.6% vs. Q222 Revenues Q223
69.53% 3.2% vs. Q222 Gross Profit Margin
6.16% 13.2% vs. Q222 Net Profit Margin
180.38B -22.6% vs. Q222 Free Cash Flow Q223
$10 0% vs. Q222 EPS Q223
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q223
0.25%
Ratios
As of
Dec 31, 2022
Sep 30, 2022
Quick Ratio
0.87
0.68
Current Ratio
0.89
1.15
Cash Ratio
0.22
0.33
Price to Book
7.36
0.66
Price to Sales
2.95
4.42
Price to Earnings
38.91
17.95